- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783527336586
3527336583
- Maße
-
25 cm
- Umfang
-
XXIX, 324 Seiten
- Ausgabe
-
[1. Auflage]
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen
- Schlagwort
-
Krebs
Onkologie
Signaltransduktion
Pharmakotherapie
Krebs
Onkologie
Forschung
Interdisziplinäre Forschung
- Ereignis
-
Veröffentlichung
- (wo)
-
Weinheim, Germany
- (wer)
-
Wiley-VCH Verlag GmbH & Co. KGaA
- (wann)
-
[2017]
- Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wagener, Christoph
- Stocking, Carol
- Müller, Oliver
- Wiley-VCH
- Wiley-VCH Verlag GmbH & Co. KGaA
Entstanden
- [2017]
Ähnliche Objekte (12)
Targeted cancer therapy
Advances in targeted cancer therapy
Successes and limitations of targeted cancer therapy
Tight junction protein signaling and cancer biology
Peptide-drug conjugates for advanced targeted cancer therapy
Metal-peptide bioconjugates for targeted anti-cancer therapy
Cancer Evolution and the Emergence of Resistance to Targeted Cancer Therapy
Value of c-MET and Associated Signaling Elements for Predicting Outcomes and Targeted Therapy in Penile Cancer
Familial Breast Cancer : Targeted Therapy in Secondary and Tertiary Prevention
Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy
Immunokinases, a novel class of immunotherapeutics for targeted cancer therapy
Targeted Therapy beim Nierenzellkarzinom
Targeted cancer therapy
Advances in targeted cancer therapy
Successes and limitations of targeted cancer therapy
Tight junction protein signaling and cancer biology
Peptide-drug conjugates for advanced targeted cancer therapy
Metal-peptide bioconjugates for targeted anti-cancer therapy
Cancer Evolution and the Emergence of Resistance to Targeted Cancer Therapy
Value of c-MET and Associated Signaling Elements for Predicting Outcomes and Targeted Therapy in Penile Cancer
Familial Breast Cancer : Targeted Therapy in Secondary and Tertiary Prevention
Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy
Immunokinases, a novel class of immunotherapeutics for targeted cancer therapy
Targeted Therapy beim Nierenzellkarzinom
Targeted cancer therapy
Advances in targeted cancer therapy
Successes and limitations of targeted cancer therapy
Tight junction protein signaling and cancer biology
Peptide-drug conjugates for advanced targeted cancer therapy
Metal-peptide bioconjugates for targeted anti-cancer therapy
Cancer Evolution and the Emergence of Resistance to Targeted Cancer Therapy
Value of c-MET and Associated Signaling Elements for Predicting Outcomes and Targeted Therapy in Penile Cancer
Familial Breast Cancer : Targeted Therapy in Secondary and Tertiary Prevention
Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy
Immunokinases, a novel class of immunotherapeutics for targeted cancer therapy